Visa Shorts V Stock analysis #shorts

AI-powered drug discovery offers hope for cystinosis patients

Artificial intelligence is becoming increasingly important in drug discovery. Advances in the use of Big Data, learning algorithms and powerful computers have now enabled researchers

July 14, 2023

Advanz Pharma’s liver disease drug pulled from European market after court hearing – Pharmaceutical Technology

Advanz said it is considering next steps, including options to enable continued access for patients. Credit: Yavdat via Shutterstock. Advanz Pharma’s liver disease drug Ocaliva

November 28, 2024

ORACLE test enhances prediction of lung cancer outcomes

A new test, developed by researchers from UCL Cancer Institute and the Francis Crick Institute, can better predict lung cancer survival at the point of

January 13, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.